Loading

Ajanta Pharma Ltd. – Q4 FY 2020-21 Earning Snapshot

 

The Sales for the quarter ended March 2021 of Rs. 7480.70 millions rose by 33.42% from Rs. 5606.80 millions. Handsome Net Profit growth of 74.87% reported above the corresponding previous quarter figure of Rs. 1547.80 millions to Rs. 885.10 millions. Operating Profit saw a handsome growth to 2484.10 millions from 1599.50 millions in the quarter ended March 2021.

 

About The Author

Related posts

Leave a Reply

Your email address will not be published.